Robert Friesen holds the position of Chief Scientific Officer of Pharming Group NV and Chief Scientific Officer at Kiadis Pharma NV.

Dr. Friesen previously held the position of Head-Preclinical & Early Clinical Development at MorphoSys AG, Senior Vice President for ProQR Therapeutics NV, Global Head-Biologics Research at Janssen Biotherapeutics, Chief Scientific Officer for Ablynx NV and Vice President-Biologics Research at Janssen Research & Development LLC.

Dr. Friesen received a doctorate from The University of Texas at Austin and a graduate degree from the University of Utrecht.